New appointment at TranScrip Partners
This article was originally published in Scrip
Executive Summary
TranScrip Partners (UK), a pharmaceutical development firm that provides advice and support to pharmaceutical and biotechnology companies, has appointed Gareth Walters partner. He has more than 20 years' experience in regulatory affairs, clinical research and product management, having most recently served as regional director of medicines development for Europe and the US at Choice Pharma. Mr Walters has also served as project leader of global regulatory affairs at Roche. After that, he joined the founding management team of Protigm, a drug development company and Roche subsidiary, which subsequently became Fulcrum Pharma.